{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Device+B&page=20", "query": { "intervention": "Device B", "page": 20 }, "page_size": 10 }, "pagination": { "page": 20, "page_size": 10, "total_count": 556, "total_pages": 56, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Device+B&page=21&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Device+B&page=19&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T03:48:41.937Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01700946", "title": "Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood B-Lymphoblastic Lymphoma" ], "interventions": [ { "name": "dexamethasone", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "rituximab", "type": "BIOLOGICAL" }, { "name": "clofarabine", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "aldesleukin", "type": "BIOLOGICAL" }, { "name": "pegaspargase", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "mercaptopurine", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" }, { "name": "mitoxantrone", "type": "DRUG" }, { "name": "teniposide", "type": "DRUG" }, { "name": "vinblastine", "type": "DRUG" }, { "name": "natural killer cell infusion", "type": "BIOLOGICAL" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "therapeutic hydrocortisone", "type": "DRUG" }, { "name": "allogeneic hematopoietic stem cell transplantation", "type": "PROCEDURE" }, { "name": "CliniMACS", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER", "PROCEDURE", "DEVICE" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 80, "start_date": "2013-04-15", "completion_date": "2021-07-24", "has_results": true, "last_update_posted_date": "2022-09-28", "last_synced_at": "2026-10-28T03:48:41.937Z", "location_count": 3, "location_summary": "San Diego, California • Memphis, Tennessee • Fort Worth, Texas", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Memphis", "state": "Tennessee" }, { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01700946" }, { "nct_id": "NCT02075229", "title": "Evaluation of Revised Indicatons (ERID) for Cochlear Implant Candidacy for the Adult CMS Population", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bilateral Sensorineural Hearing Loss" ], "interventions": [ { "name": "Cochlear implant", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "American Cochlear Implant Alliance", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 37, "start_date": "2014-02", "completion_date": "2019-09", "has_results": false, "last_update_posted_date": "2021-07-27", "last_synced_at": "2026-10-28T03:48:41.937Z", "location_count": 19, "location_summary": "Los Angeles, California • Englewood, Colorado • Miami, Florida + 16 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT02075229" }, { "nct_id": "NCT02190305", "title": "Rapid Diagnostics for HIV and Hepatitis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections", "Hepatitis B Infections", "Hepatitis C Infections" ], "interventions": [ { "name": "Multiplo HBc/HIV/HCV and Reveal HBsAg", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "MedMira Laboratories Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 0, "start_date": "2014-05", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2023-04-21", "last_synced_at": "2026-10-28T03:48:41.937Z", "location_count": 4, "location_summary": "Los Angeles, California • Miami, Florida • Minneapolis, Minnesota + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02190305" }, { "nct_id": "NCT00790829", "title": "Preemptive Use of the Nicotine Patch for Postoperative Pain Relief After Open Abdominal Surgery", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "transdermal nicotine patch", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stony Brook University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 30, "start_date": "2007-08", "completion_date": "2011-12", "has_results": false, "last_update_posted_date": "2022-01-21", "last_synced_at": "2026-10-28T03:48:41.937Z", "location_count": 1, "location_summary": "Stony Brook, New York", "locations": [ { "city": "Stony Brook", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00790829" }, { "nct_id": "NCT04940429", "title": "Eye Movement Testing in Patients With Obesity and the Impact of Weight Loss Surgery", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bariatric Surgery Candidate", "Obesity, Morbid" ], "interventions": [ { "name": "Neurofit", "type": "DEVICE" }, { "name": "Psychometric hepatic encephalopathy score", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DEVICE", "DIAGNOSTIC_TEST" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 19, "start_date": "2018-11-27", "completion_date": "2021-06-17", "has_results": false, "last_update_posted_date": "2021-06-25", "last_synced_at": "2026-10-28T03:48:41.937Z", "location_count": 1, "location_summary": "Redwood City, California", "locations": [ { "city": "Redwood City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04940429" }, { "nct_id": "NCT00801931", "title": "Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Leukemia", "Lymphoma", "Neuroblastoma", "Immunodeficiencies", "Anemia" ], "interventions": [ { "name": "Alemtuzumab", "type": "DRUG" }, { "name": "Total Body Irradiation", "type": "RADIATION" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Busulfan", "type": "DRUG" }, { "name": "Phenytoin", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Horse Antithymocyte Globulin", "type": "DRUG" }, { "name": "Rabbit Antithymocyte Globulin", "type": "DRUG" }, { "name": "Thiotepa", "type": "DRUG" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "30 Years", "sex": "ALL", "summary": "Up to 30 Years" }, "enrollment_count": 1, "start_date": "2007-09-06", "completion_date": "2009-05-05", "has_results": true, "last_update_posted_date": "2019-03-27", "last_synced_at": "2026-10-28T03:48:41.937Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00801931" }, { "nct_id": "NCT01660152", "title": "Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Male Erectile Disorder", "Prostate Cancer", "Sexual Dysfunction" ], "interventions": [ { "name": "Sexual Health Inventory for Men (SHIM) questionnaire administration", "type": "OTHER" }, { "name": "management of therapy complications", "type": "PROCEDURE" }, { "name": "Daily vacuum therapy", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "70 Years", "sex": "MALE", "summary": "Up to 70 Years · Male only" }, "enrollment_count": 2, "start_date": "2011-09", "completion_date": "2013-07-17", "has_results": false, "last_update_posted_date": "2017-04-13", "last_synced_at": "2026-10-28T03:48:41.937Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01660152" }, { "nct_id": "NCT00520455", "title": "Randomized Trial of Advanced Provision Emergency Contraception Among Women With Gonorrhea or Chlamydia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pregnancy" ], "interventions": [ { "name": "levonorgestrel 0.75mg taken twice 12 hours apart (Plan B) and condoms", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "60 Years", "sex": "FEMALE", "summary": "16 Years to 60 Years · Female only" }, "enrollment_count": 177, "start_date": "2004-01", "completion_date": "2005-06", "has_results": false, "last_update_posted_date": "2007-11-15", "last_synced_at": "2026-10-28T03:48:41.937Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00520455" }, { "nct_id": "NCT07186192", "title": "Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hematologic Malignancies" ], "interventions": [ { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Health Telemonitoring", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Best Practice", "type": "OTHER" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 380, "start_date": "2026-01-14", "completion_date": "2029-03-29", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-10-28T03:48:41.937Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07186192" }, { "nct_id": "NCT05853900", "title": "Study of Two Digital Therapeutics for the Prevention of Episodic Migraine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Migraine", "Episodic Migraine", "Headache", "Headache, Migraine" ], "interventions": [ { "name": "ReMMi-D Digital Therapeutic", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Click Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 568, "start_date": "2023-03-28", "completion_date": "2024-05-07", "has_results": true, "last_update_posted_date": "2025-07-03", "last_synced_at": "2026-10-28T03:48:41.937Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05853900" } ] }